Immuneering Corp
NASDAQ:IMRX
Income Statement
Earnings Waterfall
Immuneering Corp
Revenue
|
0
USD
|
Operating Expenses
|
-58.4m
USD
|
Operating Income
|
-58.4m
USD
|
Other Expenses
|
4.9m
USD
|
Net Income
|
-53.5m
USD
|
Income Statement
Immuneering Corp
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||
Revenue |
1
N/A
|
2
+34%
|
2
+10%
|
2
-27%
|
1
-38%
|
1
-47%
|
0
-36%
|
0
-59%
|
0
-69%
|
0
N/A
|
0
N/A
|
|
Gross Profit | ||||||||||||
Cost of Revenue |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
Gross Profit |
1
N/A
|
1
+38%
|
1
-1%
|
1
-28%
|
0
-43%
|
0
-63%
|
0
+14%
|
0
-56%
|
0
-71%
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||
Operating Expenses |
(15)
|
(24)
|
(35)
|
(41)
|
(45)
|
(49)
|
(52)
|
(54)
|
(55)
|
(56)
|
(58)
|
|
Selling, General & Administrative |
(3)
|
(5)
|
(8)
|
(11)
|
(13)
|
(15)
|
(16)
|
(16)
|
(16)
|
(16)
|
(17)
|
|
Research & Development |
(12)
|
(19)
|
(27)
|
(30)
|
(31)
|
(34)
|
(36)
|
(37)
|
(39)
|
(39)
|
(41)
|
|
Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Operating Income |
(14)
N/A
|
(23)
-60%
|
(34)
-49%
|
(41)
-20%
|
(44)
-9%
|
(49)
-11%
|
(52)
-6%
|
(54)
-3%
|
(55)
-3%
|
(56)
-1%
|
(58)
-4%
|
|
Pre-Tax Income | ||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
3
|
4
|
|
Total Other Income |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
1
|
|
Pre-Tax Income |
(14)
N/A
|
(23)
-60%
|
(34)
-49%
|
(41)
-20%
|
(44)
-9%
|
(48)
-10%
|
(51)
-4%
|
(51)
-1%
|
(52)
-1%
|
(52)
+0%
|
(53)
-4%
|
|
Net Income | ||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(14)
|
(23)
|
(34)
|
(40)
|
(44)
|
(48)
|
(51)
|
(51)
|
(52)
|
(52)
|
(53)
|
|
Net Income (Common) |
(14)
N/A
|
(23)
-60%
|
(34)
-47%
|
(40)
-20%
|
(44)
-9%
|
(48)
-10%
|
(51)
-5%
|
(51)
-1%
|
(52)
-1%
|
(52)
+0%
|
(53)
-4%
|
|
EPS (Diluted) |
-0.54
N/A
|
-1.24
-130%
|
-2.46
-98%
|
-1.52
+38%
|
-1.65
-9%
|
-1.83
-11%
|
-1.91
-4%
|
-1.94
-2%
|
-1.81
+7%
|
-1.76
+3%
|
-1.88
-7%
|